Reduced default mode network functional connectivity in patients with recurrent major depressive disorderChao‐Gan Yan, Shuqiao Yao, Tongjian Bai et al.|Proceedings of the National Academy of Sciences|2019Cited by 865
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementiaShifu Xiao, Raoli He, Piu Chan et al.|Alzheimer s Research & Therapy|2021Cited by 200